Intravenous Immune Globulin (IVIg) is an expensive and limited resource. It is prepared by several commercial manufacturers who use plasma derived from donors to produce IVIg

The BC Provincial Blood Coordinating Office (PBCO) operates an IVIg Utilization Management Program to ensure that enough IVIg is available for patients likely to benefit from the treatment.  The program incorporates the:

Two specialty panels support centralized screening of select conditions. Additional information regarding the Rheumatology and Neurology Screening Programs are found on the following corresponding pages:

        IVIg Neurology Program